Welcome to our dedicated page for Altria Group SEC filings (Ticker: MO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Altria Group, Inc. filings document formal disclosures for a U.S. tobacco and nicotine-products operating company. Form 8-K reports cover quarterly and annual results, consolidated financial statements, internal control reporting, material governance changes and completed debt issuances. The filings identify registered securities including MO common stock and exchange-listed notes, and describe senior unsecured notes and guarantees by Philip Morris USA.
Proxy materials cover annual meeting voting matters, director elections, board practices, executive compensation and pay-versus-performance disclosures. The record also includes capital-structure and financial-reporting disclosures tied to Altria's operating subsidiaries, shareholder returns, tobacco and health litigation items, FDA-regulated smoke-free products and other matters affecting its regulated consumer-products business.
ALTRIA GROUP, INC. director Marjorie Mary Connelly received an award of 2,571 shares of deferred common stock on May 14, 2026 as a grant under the 2025 Stock Compensation Plan for Non-Employee Directors. The award was granted at no cash cost per share.
After this award, Connelly directly holds 19,936 deferred shares in the plan. Footnotes note that these deferred shares include an additional 1,113 shares acquired through the reinvestment of dividends since May 15, 2025, the date of the last reportable transaction.
KELLY ENNIS DEBRA J reported acquisition or exercise transactions in this Form 4 filing.
Altria Group, Inc. director Debra J. Kelly Ennis reported routine equity compensation and updated deferred holdings. She received a grant of 2,571 shares of common stock at an award price of $0 under the 2025 Stock Compensation Plan for Non-Employee Directors, bringing her direct common stock holdings to 79,599 shares. Her deferred and phantom interests include 31,215 phantom stock units tied 1-for-1 to Altria common stock and 73,809 deferred shares in the Stock Compensation Plan for Non-Employee Directors, with both plans reflecting additional share equivalents from reinvested dividends.
Davis Robert Matthews reported acquisition or exercise transactions in this Form 4 filing.
Altria Group director Robert Matthews Davis received 2,571 shares of common stock as a stock award under the 2025 Stock Compensation Plan for Non-Employee Directors. The shares were granted at no cost and are compensation, not an open-market purchase or sale.
After this award, Davis directly holds 18,063 Altria shares. The filing also reports 178 shares of common stock held indirectly through his wife, reflecting a relatively modest overall ownership position for a board member.
SHANKS VIRGINIA E reported acquisition or exercise transactions in this Form 4 filing.
Altria Group director Virginia E. Shanks received an award of 2,571 shares of common stock as compensation. The shares were granted on a deferred basis under the 2025 Stock Compensation Plan for Non-Employee Directors at no cash cost per share. After this award, she directly holds 48,900 shares, which include 19,936 deferred shares and additional shares accumulated through the reinvestment of dividends since May 15, 2025.
ALTRIA GROUP, INC. director Mario Max Yzaguirre reported an acquisition of 2,571 shares of Common Stock on May 14, 2026 as a deferred stock award under the 2025 Stock Compensation Plan for Non-Employee Directors. The award was granted at a stated price of $0.00 per share as equity compensation, not a market purchase.
Following this grant, Yzaguirre directly holds 19,936 deferred shares in the Stock Compensation Plan for Non-Employee Directors. Footnotes state this total includes 1,113 shares acquired through reinvestment of dividends on deferred shares since the date of the last reportable transaction.
ALTRIA GROUP, INC. director Kathryn B. McQuade reported a compensation-related stock grant. She received 4,656 shares of common stock at a stated price of $0.00 per share under the 2025 Stock Compensation Plan for Non-Employee Directors, bringing her directly held common stock to 111,816 shares after the award.
She also holds phantom stock units tied to 10,446 underlying common shares, which are settled in cash on a 1-for-1 basis. Footnotes note additional deferred shares and share equivalents, including 6,671 deferred shares and 669 share equivalents acquired through dividend reinvestment since May 15, 2025.
ALTRIA GROUP, INC. reported that Chief Executive Officer Salvatore Mancuso received an award of 40,634 shares of common stock at $0.00 per share, categorized as a grant or other acquisition under the company’s equity compensation plans.
After this award, his direct holdings total 320,909 common shares, which include 123,819 Restricted Stock Units noted in the footnotes. Separately, 5,835 shares are held indirectly through the Altria Deferred Profit-Sharing Plan, reflecting retirement-related ownership rather than market trading.
Altria Group, Inc. (MO) reported higher first‑quarter profitability with modest revenue growth. Net revenues for the three months ended March 31, 2026 were $5.4 billion, up from $5.3 billion a year earlier, driven mainly by smokeable and oral tobacco products.
Net earnings rose to $2.2 billion from $1.1 billion, and basic and diluted EPS increased to $1.30 from $0.63, largely reflecting the absence of the prior‑year e‑vapor goodwill impairment. Operating income increased to $3.0 billion from $1.8 billion.
Operating cash flow was $2.3 billion, supporting dividends and $280 million of share repurchases. Long‑term debt totaled $24.6 billion, and there were about 1.67 billion common shares outstanding as of April 22, 2026. The company continues to manage significant tobacco, e‑vapor, and antitrust litigation, while its equity stakes in ABI and Cronos had fair values above their carrying amounts.
Altria Group, Inc. reported solid first-quarter 2026 results and reaffirmed its full-year adjusted diluted EPS guidance of $5.56 to $5.72, a projected 2.5% to 5.5% increase from $5.42 in 2025. Net revenues rose 3.2% to $5.4 billion and revenues net of excise taxes grew 5.3% to $4.8 billion, driven mainly by smokeable products.
Reported diluted EPS more than doubled to $1.30, reflecting higher operating income and lapping prior-year impairment charges, while adjusted diluted EPS increased 7.3% to $1.32. The smokeable products segment delivered 5.2% growth in revenues net of excise taxes and 6.3% growth in adjusted operating companies income, with higher margins. Oral tobacco products posted modest revenue and income growth but continued share pressure.
Altria returned substantial cash to shareholders, repurchasing 4.5 million shares for $280 million at an average price of $62.33 and paying $1.8 billion in dividends in the quarter. Management plans 2026 earnings growth that considers moderated e-vapor growth, macroeconomic uncertainty for adult nicotine consumers, and ongoing investments in its strategic initiatives.
Vanguard Capital Management reports beneficial ownership of 125,533,942 shares of Altria Group Inc. under a Schedule 13G filing, representing 7.50% of the outstanding common stock as of 03/31/2026. Vanguard discloses sole dispositive power over 125,533,942 shares and sole voting power over 16,697,900 shares. The filing states these holdings include securities held by Vanguard funds and related advisory entities and is signed on 04/29/2026.